Ironwood Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2008 | — | — | $66.3M |
| FY2009 | — | — | $122.3M |
| FY2010 | $141.8M | $301.4M | $44.3M |
| FY2011 | $99.1M | $209.0M | $87.3M |
| FY2012 | $85.9M | $229.9M | $136.7M |
| FY2013 | $240.7M | $279.0M | $75.5M |
| FY2014 | $240.8M | $329.3M | $74.3M |
| FY2015 | $524.0M | $619.1M | $261.3M |
| FY2016 | $643.1M | $709.8M | $54.0M |
| FY2017 | $595.8M | $605.7M | $125.7M |
| FY2018 | $528.4M | $332.1M | $173.2M |
| FY2019 | $496.0M | $402.7M | $177.0M |
| FY2020 | $496.6M | $559.2M | $362.6M |
| FY2021 | $521.0M | $1.13B | $620.1M |
| FY2022 | $448.1M | $1.10B | $656.2M |
| FY2023 | $817.4M | $471.1M | $92.2M |
| FY2024 | $652.2M | $350.9M | $88.6M |
| FY2025 | $658.7M | $396.9M | $215.5M |